Matches in Nanopublications for { ?s ?p "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP128814.RAVxa1N3GDeaZbzFm4xbRM21F7qkG8PQK0nsYznsfOqq8130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP128814.RAVxa1N3GDeaZbzFm4xbRM21F7qkG8PQK0nsYznsfOqq8130_provenance.
- NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP154079.RAfKv1aZ0VL9m2lvpdVx9w1wnXzPgVeFTtULmXJeOi1z4130_provenance.
- NP191992.RAa2pIpiOkMVBjBoYI6fIJNIEMHa6lqnx1ChAdRcls8aU130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP191992.RAa2pIpiOkMVBjBoYI6fIJNIEMHa6lqnx1ChAdRcls8aU130_provenance.
- NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217184.RA4ujhUdblzPK8lOiMSeUGtZaZa7k-N29k6jDZ4OdVLkg130_provenance.
- NP244934.RAR-04RzZOBKkB-M7EvZu9EZ2P37YbG798MheeZK5py_E130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244934.RAR-04RzZOBKkB-M7EvZu9EZ2P37YbG798MheeZK5py_E130_provenance.
- assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_assertion description "[We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia/severity of EA6 symptoms is related to the extent of glutamate transporter dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244935.RAMesaSEqAKta_vcW3jUGP5NOr-dB-cXlPSXApFGNXDVs130_provenance.